{"name":"Noema Pharma AG","slug":"noema-pharma-ag","ticker":"","exchange":"","domain":"noemapharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NOE-105","genericName":"NOE-105","slug":"noe-105","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"NOE-105","genericName":"NOE-105","slug":"noe-105","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPckNPRmUxZ2lPVHNKMXRzbm5MaThmUm9kbjRzclhUYzhaZTEyRXZKVG5qNEdsUHBiSlVzM0pNcEhXWG1OMW5acmZhOVhETEw5T0xvYkVKdTNySEItUEZBbXdkWjJ5T3hlMzllX1cxMzhGeGVfWmlvTVZXUFJYUUFKU3htYWtfdzZCTWpXb1l5WFpzSnpFVm1DOE5zU3lyWUppdWhRNEk4TEQwTkpDWk5QNDRwQTJIZURpYllLd3l6WE5nTURnRlNZY1R0V1JBd2c3djVUeFBqYkNLcC1PZFYwTFExRjM4cnI3MWltT2VmX2FoTDYxbkIzZHkzVjBxalZBVHBMMFE2YkpFV3V5aTFxdVF6MjRsbU52Y0dDdUk5c2RjSUE?oc=5","date":"2025-11-06","type":"regulatory","source":"GlobeNewswire","summary":"Noema Pharma Announces Phase 2a Study Results with - GlobeNewswire","headline":"Noema Pharma Announces Phase 2a Study Results with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPWENobEl5T2FMbnhGZGRQOHZZbkhpcm16eFRFRE5JOUlxV0NEckxaT1pBa1YwSGJyeFJiZHc1T0NheGR0dWRkUU9MUTRWTk1MUWlabnRiMEhDUXVsTlZtb3J3Ukp4NmRSTG5GSWtrQk94OC1uOWhYeEpNQUJLakxWYkxlbXg3cjJ1QU1rbg?oc=5","date":"2024-12-18","type":"regulatory","source":"Yahoo Finance","summary":"Noema Pharma Appoints Volker Knappertz, M.D., as Executive Vice President of Research & Development - Yahoo Finance","headline":"Noema Pharma Appoints Volker Knappertz, M.D., as Executive Vice President of Research & Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZ1NRY1Q1YXdYcUR3UENsQjlsOWxCV2U0M19iUHBBSzFyOFQxVDNWT1p1a2JQeUVMX0ZoQVJuUGlCd29RRzNSeW54ZkhBejVyRF8yVndIeXMtcXExY2QxX1h1U1dWaWNUbzFPbnNjTDFNLTlJRHNaeVhFZVltd3VXaDNGNGZXY3VmV1I1Wm5fRkRtbUVVM0N0WnRCWmZyR0hORFl4eGE4ZlRFLVlhMDVKbHUybHBXZkFMUTZ2Zk5KUlY3SjhjZnhOMTI5UldsTmlvS05Eb1BoYnJ5eXRk?oc=5","date":"2024-12-11","type":"regulatory","source":"businesswire.com","summary":"Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million) - businesswire.com","headline":"Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPeFlXU1I5cU43QTFfd1hmSDJ4aDJSaHN4LUo3MTRFem5nSGhGQi12QXo1Z1doQWV4eU9fTV9YWThzWjR4YTlkbXZzNGJydU1VSU4xTlRkWGh0UzVRWXlkLWFHZ0ZYOTNhR2lxV3NaSUZ4aWUzR3ZJbDhZYlBldnFVM000NHdLZw?oc=5","date":"2024-10-17","type":"regulatory","source":"Yahoo Finance UK","summary":"Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints - Yahoo Finance UK","headline":"Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPdlczam14YzMyQkI5V2hMNzI5SzdpQ0JrZVo4dFRCQ0U4V0R3YmJQcXRRY1lsRDNJMXU3dmctU1hQS2pRUHRLTVFvR0dIZDViWFROTC1hRlRuckZOUjFBX2hDVERrbExtUkR2WThpVTNmZzBWeUpuOXRPdTk5bFNYV1p2eDAydUVtRnFWeUhTX2JyNG1BZlJrUHJzNW10aVlLQ2JnYVhQMjZNekJ0LXQySHgwN2M1QQ?oc=5","date":"2023-07-04","type":"pipeline","source":"startupticker.ch","summary":"New executives to drive Life sciences and Fintech startups on the next journey - startupticker.ch","headline":"New executives to drive Life sciences and Fintech startups on the next journey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQMkh0d0JDdnlVSkZ4Y1lJVFFwUWNoVlNhWWU1cGFCRVFlX0twWTZUMnFYU1BHQVE5LVRLMmY3dWgwd3B5aEpoOVdzZHlTa3otMDdMdXplSDJUNldEZnlHYkhuMmxsRFpuWmNyeUpQQzhvbTRjdDN3ZG1TVVk4Z1hLa1hEeFlLVlBsVU56eDZKSmlDN3Jx?oc=5","date":"2022-07-29","type":"trial","source":"globaldata.com","summary":"Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeFU3QlpsQmJfSGtaVDNUZzZyTWQ4c0FNNU9uenNHbkdTRUJGdFMzY251X3piaVFIWnBoRU01MzdIM0FPeGk3THl2NUV1UFYtd2plaUhPa25xR1BteWw1Q0IzR2czRTlEVzlmT1NlX3AzT1p5QjJJbWZaMmNFZF9mYVdNS2k5LVVqMm5INjIxS3J5bUVBbzZLaWZXU29zWkxXS1RHeXB5ajhlZw?oc=5","date":"2020-12-01","type":"regulatory","source":"BioWorld News","summary":"Noema raises $60M to move Roche assets into orphan CNS indications - BioWorld News","headline":"Noema raises $60M to move Roche assets into orphan CNS indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPRkxoM2N3V0RjMzQ0UkZaN25SazZHb095azFqdkpUNVM5WTR1Y1NlLTZDVHVFRnowRkt1NG9rb25TYzdTZEd1dGphb2hPeTNCaG9DRWY2YXRSVldaczEzRlYxa0lnZlM2ZEJJUVZyaTVTclpXYXY2NHpFZGsxRXUzMmF1QkFJVkt3RWhWcDFKYmRWS0VBUHp4U3ppNnhmUmpoX204TWJhSVpXenBrTEo3eDN4Y1VuSWRNMlFIODBQTXJQc1FMdjdXeE9wY25XWE11a2kzMDZWMGd4c1pjMGxVTG05emktVzB4dzVUNzMzTWdBeDF4c3RVVVRWcVFoTnpoQVMzdEdId0lIbnZT?oc=5","date":"2020-12-01","type":"regulatory","source":"GlobeNewswire","summary":"Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners - GlobeNewswire","headline":"Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}